Short answer · Medically reviewed summary · Last updated: 2026-04-07
Goodpasture syndrome is classified under the ICD-10 code M31.0 (Goodpasture’s syndrome) and the ICD-9 code 446.21 (Goodpasture’s syndrome). These standardized codes are essential for medical billing, clinical documentation, and tracking the prevalence of this rare autoimmune disorder within global health systems. What is the clinical nature of Goodpasture syndrome? Goodpasture syndrome, also known as anti-glomerular basement membrane (anti-GBM) disease, is a rare autoimmune condition where the body’s immune system produces antibodies that attack the basement membranes in the kidneys and the lungs.
2 people with Goodpasture syndrome have shared their first-person experience on this question at DiseaseMaps.
Goodpasture syndrome is classified under the ICD-10 code M31.0 (Goodpasture’s syndrome) and the ICD-9 code 446.21 (Goodpasture’s syndrome). These standardized codes are essential for medical billing, clinical documentation, and tracking the prevalence of this rare autoimmune disorder within global health systems.
Goodpasture syndrome, also known as anti-glomerular basement membrane (anti-GBM) disease, is a rare autoimmune condition where the body’s immune system produces antibodies that attack the basement membranes in the kidneys and the lungs. Because Goodpasture syndrome can lead to rapidly progressive glomerulonephritis and pulmonary hemorrhage, prompt medical identification using the correct ICD codes is critical for securing insurance coverage for urgent treatments like plasmapheresis and immunosuppressive therapy. At DiseaseMaps.org, 108 people with Goodpasture syndrome have joined our community, helping to map the diagnostic journeys and treatment outcomes of others facing this challenging condition.
Medical coding provides a universal language for healthcare providers to describe Goodpasture syndrome. While ICD-10-CM (Clinical Modification) code M31.0 is the current standard in the United States and many other countries, the older ICD-9 code 446.21 is still occasionally encountered in historical medical records. Accurate coding is vital for several reasons:
The diagnosis of Goodpasture syndrome is typically confirmed through a combination of clinical findings, serological tests, and tissue biopsy. Clinicians look for the presence of circulating anti-GBM antibodies in the blood via ELISA testing. In Goodpasture syndrome, a kidney biopsy often reveals a "linear" pattern of IgG deposition along the glomerular basement membrane when viewed under immunofluorescence microscopy. Because this is a medical emergency, rapid coordination between nephrologists and pulmonologists is necessary to mitigate long-term organ damage.
Living with a rare, life-threatening illness like Goodpasture syndrome is physically and emotionally taxing. The uncertainty of kidney function and the intensity of immunosuppressive treatments can lead to significant psychological distress, including anxiety and depression. Connecting with others who share the diagnosis can provide a sense of validation. Our community of 108 members at DiseaseMaps.org offers a space where those affected by Goodpasture syndrome can share experiences, coping strategies, and support, which is an invaluable component of the healing process alongside medical intervention.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.